Pteridines as FGFR inhibitors
US10272087B2 · kind B2 · utility
5Cited by
34References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 6, 2016 |
| Grant date | Apr 30, 2019 |
| Priority date | — |
| Expiry date | Jul 6, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D475/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new pteridine derivative compounds, of formula (I), to pharmaceutical compositions comprising said compounds, to processes for the preparation of said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.